EBITDA: Income before interest, taxes, depreciation and amortization.
Immunic, Inc. (IMUX) had EBITDA of $-23.29M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-19.30M |
|
-- |
|
-- |
|
$23.33M |
|
$-23.33M |
|
$4.03M |
|
$-19.30M |
|
$-19.30M |
|
$-19.30M |
|
$-19.30M |
|
$-19.30M |
|
$-19.30M |
|
$-23.33M |
|
|
EBITDA |
$-23.29M |
155.69M |
|
155.69M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$22.87M |
|
$0.61M |
|
$1.18M |
|
$24.05M |
|
$30.62M |
|
-- |
|
$0.11M |
|
$30.73M |
|
$-6.67M |
|
$-6.67M |
|
$-6.67M |
|
120.38M |
|
| Cash Flow Statement Financials | |
$-85.81M |
|
$-0.16M |
|
$65.58M |
|
$35.67M |
|
$15.48M |
|
$-20.18M |
|
$8.86M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.75 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-85.97M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
289.23% |
|
289.23% |
|
-80.24% |
|
289.23% |
|
$-0.06 |
|
$-0.55 |
|
$-0.55 |
|